Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America

BACKGROUND: Although RT-qPCR remains the gold-standard for COVID-19 diagnosis, anti-SARS-CoV-2 serology-based assays have been widely used during 2020 as an alternative for individual and mass testing, and are currently used for seroprevalence studies. OBJECTIVE: To study the clinical performance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Olivero, Ismar A., Henríquez-Trujillo, Aquiles R., Kyriakidis, Nikolaos C., Ortiz-Prado, Esteban, Laglaguano, Juan Carlos, Vallejo-Janeta, Alexander Paolo, Lozada, Tannya, Garcia-Bereguiain, Miguel Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894897/
https://www.ncbi.nlm.nih.gov/pubmed/35252025
http://dx.doi.org/10.3389/fcimb.2022.787987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894897/
https://www.ncbi.nlm.nih.gov/pubmed/35252025
http://dx.doi.org/10.3389/fcimb.2022.787987

Ejemplares similares